Table: Taiko Pharmaceutical - 6-MTH group results

Taiko Pharmaceutical

06/08/2021 07:01

Aug 6 (Reuters)- 
             Taiko Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   6 months ended      6 months ended        Year to  
                  Jun 30, 2021        Sep 30, 2020      Dec 31, 2021  
                     LATEST             YEAR-AGO           LATEST     
                     RESULTS             RESULTS          FORECAST    
  Sales               5.11                10.97             12.50     
  Operating         loss 2.28              4.24           loss 2.00   
  Recurring         loss 2.74              4.11           loss 3.40   
  Net               loss 2.37              2.86           loss 2.80   
  EPS            loss 54.62 yen         66.29 yen      loss 64.24 yen 
  EPS Diluted                           65.95 yen                     
  Ann Div                               25.00 yen            NIL      
  -Q2 div              NIL              7.00 yen                      
  -Q4 div                               18.00 yen            NIL      
  
  NOTE - Taiko Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4574.T